The FDA placed some balloon pumps on its medical device shortage list Dec. 2, which the agency said was because of increased demand and shortage of some of the product’s components. There is a ...
Inserting intra-aortic balloon pumps prior to angioplasty in patients with acute myocardial infarction does not reduce the scope of heart muscle damage, a condition referred to as infarct size, ...
WAYNE, N.J., Maquet Getinge Group announced today the publication of a manuscript describing the exploration of the hemodynamic effects of the newer, larger-capacity 50 cc intra-aortic balloon pumps ...
Intra-aortic balloon pump (IABP) therapy fails to reduce infarct size or improve clinical outcomes when added prior to primary percutaneous coronary intervention (PCI) in patients with high-risk ...
A Japanese study of intra-aortic balloon pumps appears to indicate the devices do little to improve outcomes for patients with acute cases and may increase the chances of death. In the registry study ...
Augusta, Ga. – The most frequently used mechanical circulatory assist device in the world may have untapped potential, physicians say. One of many uses for the intra-aortic balloon pump is helping ...
LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has announced a new agreement with HealthTrust Purchasing ...
WAYNE, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced FDA 510(k) clearance of the AC3 Range™ Intra-Aortic ...
SILVER SPRING, MD — Datascope Corp/Maquet has initiated a worldwide "field correction" of certain intra-aortic balloon pump (IABP) systems to address potential electrical test failures, a MedWatch ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The FDA has designated Arrow International’s recall of ...
The company now expects 2025 adjusted constant currency growth of 6.9% to 7.4%. Adjusted revenue growth guidance for 2025 is now 8% to 8.5%, down from the prior 8.5% to 9.5%, with a revenue dollar ...